This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager patientINFORMation Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Utzschneider, K. M. Articles by Schwartz, R. S. Search for Related Content PubMed PubMed Citation Articles by Utzschneider, K. M. Articles by Schwartz, R. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Medline Plus Health Information Diabetes Diets Obesity Weight Control

Diet-Induced Weight Loss Is Associated with an Improvement in ß-Cell Function in Older Men

Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine (K.M.U., S.E.K.), Veterans Affairs Puget Sound Health Care System and Harborview Medical Center, University of Washington, Seattle, Washington 98108; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Department of Medicine (D.B.C.), University of Washington, Seattle, Washington; and Medicine/Gerontology and Geriatric Medicine, Department of Medicine (S.M.B., R.S.S.), Harborview Medical Center and University of Washington, Seattle, Washington

Address all correspondence and requests for reprints to: Kristina M. Utzschneider, M.D., Veterans Affairs Puget Sound Health Care System (151), 1660 South Columbian Way, Seattle, Washington 98108. E-mail: kutzschn{at}u.washington.edu.

Although weight loss in older subjects has been shown to improve insulin sensitivity, it is unclear what effect this lifestyle intervention has on ß-cell function. To determine whether diet-induced weight loss can improve ß-cell function in older subjects, we studied 19 healthy male subjects (age, 65.4 ± 0.9 yr; body mass index, 30.9 ± 0.6 kg/m²; mean ± SEM) before and after a 3-month 1200-kcal/d diet. The insulin sensitivity index (S_I) was quantified using Bergman’s minimal model. The acute insulin response to glucose (AIRg) and the maximal glucose-potentiated insulin response (AIRmax) were determined and then adjusted for S_I (S_I x AIRg and S_I x AIRmax), thus providing measures of ß-cell function. Subjects demonstrated significant weight loss (95.6 ± 2.4 to 86.1 ± 2.5 kg; P < 0.001). Both fasting plasma glucose [97.3 ± 1.6 to 95.1 ± 1.3 mg/dl (5.4 ± 0.09 to 5.3 ± 0.07 mM); P = 0.05] and insulin [18.5 ± 1.3 to 12.2 ± 1.0 µU/ml (110.9 ± 7.7 to 73.5 ± 5.9 pM); P < 0.001] levels decreased. With weight loss, S_I increased [1.59 ± 0.24 to 2.49 ± 0.32 x 10^–4 min^–1/(µU/ml) (2.65 ± 0.4 to 4.15 ± 0.5 x 10^–5 min^–1/pM); P < 0.001], whereas both AIRg [63.4 ± 13.4 to 51.0 ± 10.7 µU/ml (380 ± 80 to 306 ± 64 pM); P < 0.05] and AIRmax [314 ± 31.4 to 259.9 ± 33.4 µU/ml (1886 ± 188 to 1560 ± 200 pM); P < 0.05] decreased. Overall ß-cell function improved (S_I x AIRg, 9.63 ± 2.28 to 12.78 ± 2.58 x 10^–3 min^–1, P < 0.05; and S_I x AIRmax, 51.01 ± 9.2 to 72.69 ± 13.4 x 10^–3 min^–1, P < 0.05). Thus, the weight loss-associated improvements in both insulin sensitivity and ß-cell function may explain the beneficial effects of a lifestyle intervention on delaying the development of diabetes in older subjects.

This work was supported by the Medical Research Service of the Department of Veteran Affairs and National Institutes of Health Grants AG-08673, DK-02654, DK-17047, T32 HL-07028, and RR-37.

Abbreviations: AIR, Acute insulin response; AIRarg, AIR to arginine; AIRg, AIR to iv glucose; AIRmax, maximal glucose-potentiated insulin response; BMI, body mass index; DI, disposition index; DPP, Diabetes Prevention Program; FSIGT, frequently sampled iv glucose tolerance; GCRC, General Clinical Research Center; IAF, intraabdominal fat; IGT, impaired glucose tolerance; K_g, glucose disappearance constant; PG50, glucose level at 50% AIRmax; S_I, insulin sensitivity index; SQAF, sc abdominal fat.

Find additional patient-related information at:

Weight Loss Linked To Better Beta-Cell Function

This article has been cited by other articles:

				C. J. Bloem and A. M. Chang Short-Term Exercise Improves {beta}-Cell Function and Insulin Resistance in Older People with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 387 - 392. [Abstract] [Full Text] [PDF]

				N. Rasouli, H. J. Spencer, A. A. Rashidi, and S. C. Elbein Impact of Family History of Diabetes and Ethnicity on -Cell Function in Obese, Glucose-Tolerant Individuals J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4656 - 4663. [Abstract] [Full Text] [PDF]

				T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF]

				M. Cnop, J. Vidal, R. L. Hull, K. M. Utzschneider, D. B. Carr, T. Schraw, P. E. Scherer, E. J. Boyko, W. Y. Fujimoto, and S. E. Kahn Progressive Loss of {beta}-Cell Function Leads to Worsening Glucose Tolerance in First-Degree Relatives of Subjects With Type 2 Diabetes Diabetes Care, March 1, 2007; 30(3): 677 - 682. [Abstract] [Full Text] [PDF]

				N. Rasouli, P. A Kern, E. A. Reece, and S. C. Elbein Effects of pioglitazone and metformin on beta-cell function in nondiabetic subjects at high risk for type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E359 - E365. [Abstract] [Full Text] [PDF]

				The Diabetes Prevention Program Research Group [Pr The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1075 - 1081. [Abstract] [Full Text] [PDF]

				K. M. Utzschneider, R. L. Prigeon, D. B. Carr, R. L. Hull, J. Tong, J. B. Shofer, B. M. Retzlaff, R. H. Knopp, and S. E. Kahn Impact of Differences in Fasting Glucose and Glucose Tolerance on the Hyperbolic Relationship Between Insulin Sensitivity and Insulin Responses Diabetes Care, February 1, 2006; 29(2): 356 - 362. [Abstract] [Full Text] [PDF]

				D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF]

				The Diabetes Prevention Program Research Group Role of Insulin Secretion and Sensitivity in the Evolution of Type 2 Diabetes in the Diabetes Prevention Program: Effects of Lifestyle Intervention and Metformin Diabetes, August 1, 2005; 54(8): 2404 - 2414. [Abstract] [Full Text] [PDF]

				D. B. Carr, K. M. Utzschneider, E. J. Boyko, P. J. Asberry, R. L. Hull, K. Kodama, H. S. Callahan, C. C. Matthys, D. L. Leonetti, R. S. Schwartz, et al. A Reduced-Fat Diet and Aerobic Exercise in Japanese Americans With Impaired Glucose Tolerance Decreases Intra-Abdominal Fat and Improves Insulin Sensitivity but not {beta}-Cell Function Diabetes, February 1, 2005; 54(2): 340 - 347. [Abstract] [Full Text] [PDF]